Huard is one of the world’s best cell biologists researching the potential therapeutic usage of stem cells. He presently is working with the stem cells he found out while searching for an end to Duchene muscular dystrophy , a genetic disease that’s estimated to affect one in every 3,500 males. DMD is the most common type of muscular dystrophy impacting children and patients frequently die in early adulthood because of heart damage. In addition to searching for a cure for DMD, Dr.This staffing reduction was accompanied by adjustments in the organizational framework to boost the efficiencies of procedures. Paul Goddard, ARYx chairman and chief executive officer. As we out-permit those programs, our degree of personnel must today be appropriate for the demands of earlier stage compounds. We remain entirely dedicated to our strategy of discovering drug candidates that make established therapies safer internally, and developing them sufficiently to entice a big pharmaceutical company partner because of its final development and eventual commercialization.